Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a ...
Organogenesis received confirmation to initiate a license application with the Food and Drug Administration for its knee condition treatment ReNu. The regenerative tissue company said Monday it plans ...
Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...
Street vendors abound in many Queens commercial hubs, including Corona Plaza and downtown Flushing.That could be even more ...
Huonslab files BLA for HYDIZYMEâ„¢, targeting MFDS approval in 2026 for its recombinant human hyaluronidase using HyDIFFUZEâ„¢.
Savara Inc. (Nasdaq: SVRA ) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI B ...
Here are the violations reported in food safety inspection reports from Montgomery County conducted the week of Dec. 7-13, ...
The Douglas County Health Department reminds businesses that new permits are required by Jan. 1 to continue operating legally ...
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product ...
Food Not Bomb's meal share can continue thanks to a city permit applied by an unknown person. Organizers push back and demand ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback